newsfilter
← Latest News
GlobeNewswire·

Checkmate Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides an Update on Recent Progress

Successfully completed IPO in August 2020 raising $76.6 million in gross proceedsOn track to initiate planned new clinical trials in melanoma and head and neck cancer CAMBRIDGE, Mass., Sept. 18,...